Ilia Tamarin

Tel Litwinsky, TA, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Factor XI Deficiency in apoE/FXI Double-Knockout Mice Decreases Atherosclerosis by Lowering MSR1 mRNA Expression Within the Plaque.

Factor XI Deficiency in apoE/FXI Double-Knockout Mice Decreases Atherosclerosis by Lowering MSR1 mRNA Expression Within the Plaque.

Journal: Journal of lipid and atherosclerosis
Published: February 12, 2025

Rivaroxaban treatment among children with cancer-associated thromboembolism: Real-world data.

Rivaroxaban treatment among children with cancer-associated thromboembolism: Real-world data.

Journal: Pediatric blood & cancer
Published: May 26, 2022

Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin-induced thrombocytopenia.

Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin-induced thrombocytopenia.

Journal: Pediatric blood & cancer
Published: May 08, 2022

The potential role of emicizumab prophylaxis in severe von Willebrand disease.

The potential role of emicizumab prophylaxis in severe von Willebrand disease.

Journal: Blood cells, molecules & diseases
Published: October 11, 2020

Emicizumab treatment and monitoring in a paediatric cohort: real-world data.

Emicizumab treatment and monitoring in a paediatric cohort: real-world data.

Journal: British journal of haematology
Published: March 22, 2020

Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery.

Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery.

Journal: Thrombosis and haemostasis
Published: September 08, 2019

Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).

Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: July 13, 2019

A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.

A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.

Journal: Frontiers in neurology
Published: June 23, 2018

Thromboelastography during coronary artery bypass grafting surgery of severe hemophilia A patient - the effect of heparin and protamine on factor VIII activity.

Thromboelastography during coronary artery bypass grafting surgery of severe hemophilia A patient - the effect of heparin and protamine on factor VIII activity.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: June 09, 2016

The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro.

The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro.

Journal: PloS one
Published: May 18, 2016

Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice.

Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 26, 2015

Assessment of Functional Fibrinolysis in Cord Blood Using Modified Thromboelastography.

Assessment of Functional Fibrinolysis in Cord Blood Using Modified Thromboelastography.

Journal: Pediatric blood & cancer
Published: September 21, 2015
Showing 1-12 of 17

Last Updated: 09/26/2026